Previous Article | Next Article 
J Virol. 1988 November; 62(11): 3928-3933
Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells.
U Kontny,
I Kurane and
F A Ennis
Department of Medicine, University of Massachusetts Medical Center, Worcester 01605.
ABSTRACT
It has been reported that anti-dengue antibodies at subneutralizing concentrations augment dengue virus infection of monocytic cells. This is due to the increased uptake of dengue virus in the form of virus-antibody complexes by cells via Fc gamma receptors. We analyzed the effects of recombinant human gamma interferon (rIFN-gamma) on dengue virus infection of human monocytic cells. U937 cells, a human monocytic cell line, were infected with dengue virus in the form of virus-antibody complexes after rIFN-gamma treatment. Pretreatment of U937 cells with rIFN-gamma resulted in a significant increase in the number of dengue virus-infected cells and in the yield of infectious virus. rIFN-gamma did not augment dengue virus infection when cells were infected with virus in the absence of anti-dengue antibodies. Gamma interferon (IFN-gamma) produced by peripheral blood lymphocytes from dengue-immune donors after in vitro stimulation with dengue antigens also augmented dengue virus infection of U937 cells. IFN-gamma did not augment dengue virus infections when cells were infected with virus in the presence of F(ab')2 prepared from anti-dengue immunoglobulin G. Human immunoglobulin inhibited IFN-gamma-induced augmentation. IFN-gamma increased the number of Fc gamma receptors on U937 cells. The increase in the percentage of dengue antigen-positive cells correlated with the increase in the number of Fc gamma receptors after rIFN-gamma treatment. These results indicate that IFN-gamma-induced augmentation of dengue virus infection is Fc gamma receptor mediated. Based on these results we conclude that IFN-gamma increases the number of Fc gamma receptors and that this leads to an augmented uptake of dengue virus in the form of dengue virus-antibody complexes, which results in augmented dengue virus infection.
J Virol. 1988 November; 62(11): 3928-3933
This article has been cited by other articles:
-
Meyer, K., Ait-Goughoulte, M., Keck, Z.-Y., Foung, S., Ray, R.
(2008). Antibody-Dependent Enhancement of Hepatitis C Virus Infection. J. Virol.
82: 2140-2149
[Abstract]
[Full Text]
-
Blackley, S., Kou, Z., Chen, H., Quinn, M., Rose, R. C., Schlesinger, J. J., Coppage, M., Jin, X.
(2007). Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro. J. Virol.
81: 13325-13334
[Abstract]
[Full Text]
-
Mott, K. R., Osorio, Y., Maguen, E., Nesburn, A. B., Wittek, A. E., Cai, S., Chattopadhyay, S., Ghiasi, H.
(2007). Role of Anti-Glycoproteins D (Anti-gD) and K (Anti-gK) IgGs in Pathology of Herpes Stromal Keratitis in Humans. IOVS
48: 2185-2193
[Abstract]
[Full Text]
-
Brown, M. G., King, C. A., Sherren, C., Marshall, J. S., Anderson, R.
(2006). A dominant role for Fc{gamma}RII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J. Leukoc. Biol.
80: 1242-1250
[Abstract]
[Full Text]
-
Rodrigo, W. W. S. I., Jin, X., Blackley, S. D., Rose, R. C., Schlesinger, J. J.
(2006). Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc{gamma}RIA (CD64) or Fc{gamma}RIIA (CD32).. J. Virol.
80: 10128-10138
[Abstract]
[Full Text]
-
Malavige, G N, Fernando, S, Fernando, D J, Seneviratne, S L
(2004). Dengue viral infections. Postgrad. Med. J.
80: 588-601
[Abstract]
[Full Text]
-
Shresta, S., Kyle, J. L., Snider, H. M., Basavapatna, M., Beatty, P. R., Harris, E.
(2004). Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical. J. Virol.
78: 2701-2710
[Abstract]
[Full Text]
-
GWINN, W., SUN, W., INNIS, B. L., CAUDILL, J., KING, A. D.
(2003). SEROTYPE-SPECIFIC TH1 RESPONSES IN RECIPIENTS OF TWO DOSES OF CANDIDATE LIVE-ATTENUATED DENGUE VIRUS VACCINES. Am J Trop Med Hyg
69: 39-47
[Abstract]
[Full Text]
-
Cologna, R., Rico-Hesse, R.
(2003). American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells. J. Virol.
77: 3929-3938
[Abstract]
[Full Text]
-
Lin, Y.-W., Wang, K.-J., Lei, H.-Y., Lin, Y.-S., Yeh, T.-M., Liu, H.-S., Liu, C.-C., Chen, S.-H.
(2002). Virus Replication and Cytokine Production in Dengue Virus-Infected Human B Lymphocytes. J. Virol.
76: 12242-12249
[Abstract]
[Full Text]
-
Glansbeek, H. L., Haagmans, B. L., te Lintelo, E. G., Egberink, H. F., Duquesne, V., Aubert, A., Horzinek, M. C., Rottier, P. J. M.
(2002). Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus. J. Gen. Virol.
83: 1-10
[Abstract]
[Full Text]
-
Lidbury, B. A., Mahalingam, S.
(2000). Specific Ablation of Antiviral Gene Expression in Macrophages by Antibody-Dependent Enhancement of Ross River Virus Infection. J. Virol.
74: 8376-8381
[Abstract]
[Full Text]
-
Diamond, M. S., Edgil, D., Roberts, T. G., Lu, B., Harris, E.
(2000). Infection of Human Cells by Dengue Virus Is Modulated by Different Cell Types and Viral Strains. J. Virol.
74: 7814-7823
[Abstract]
[Full Text]
-
Diamond, M. S., Roberts, T. G., Edgil, D., Lu, B., Ernst, J., Harris, E.
(2000). Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons. J. Virol.
74: 4957-4966
[Abstract]
[Full Text]
Copyright © 1988 by the American Society for Microbiology. All rights reserved.